Trials / Terminated
TerminatedNCT01078844
Memantine in Adult Autism Spectrum Disorder
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 4 (actual)
- Sponsor
- Johns Hopkins University · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to see if memantine is helpful in managing problematic symptoms in adults with autism, Asperger's disorder, or Pervasive Developmental Disorder not otherwise specified (NOS).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | memantine | memantine 5-20 mg daily |
| DRUG | Placebo | Look-alike placebo |
Timeline
- Start date
- 2010-02-01
- Primary completion
- 2010-07-01
- Completion
- 2010-07-01
- First posted
- 2010-03-02
- Last updated
- 2017-07-26
- Results posted
- 2017-07-26
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01078844. Inclusion in this directory is not an endorsement.